about
The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic inventionBenzo(a)pyrene-caused increased G(1)-S transition requires the activation of c-Jun through p53-dependent PI-3K/Akt/ERK pathway in human embryo lung fibroblastsCyclin D1 interacts and collaborates with Ral GTPases enhancing cell detachment and motilityRegulation of PCNA and cyclin D1 expression and epithelial morphogenesis by the ZO-1-regulated transcription factor ZONAB/DbpAPACSIN 2 represses cellular migration through direct association with cyclin D1 but not its alternate splice form cyclin D1bAlternative cyclin D1 splice forms differentially regulate the DNA damage responseGrowth control by intracellular tension and extracellular stiffnessmiR-16 family induces cell cycle arrest by regulating multiple cell cycle genes.Role of desumoylation in the development of prostate cancerAP-2gamma induces p21 expression, arrests cell cycle, and inhibits the tumor growth of human carcinoma cellsHepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genesCommon stemness regulators of embryonic and cancer stem cellsAmplification of Cellular Oncogenes in Solid TumorsTargeting CDK6 in cancer: State of the art and new insightsmiRNAs in breast cancer tumorigenesis (Review)Molecular genetics of adrenocortical tumor formation and potential pharmacologic targetsSmall non-coding RNAs govern mammary gland tumorigenesisAnimal models to study the mutational landscape for oral cavity and oropharyngeal cancersProtein kinase A activity and anchoring are required for ovarian cancer cell migration and invasionExpression and knockdown of zebrafish folliculin suggests requirement for embryonic brain morphogenesis.Dietary administration of scallion extract effectively inhibits colorectal tumor growth: cellular and molecular mechanisms in miceActivation of Ribosomal RNA Transcription by Hepatitis C Virus Involves Upstream Binding Factor Phosphorylation via Induction of Cyclin D1D-type Cyclins are important downstream effectors of cytokine signaling that regulate the proliferation of normal and neoplastic mammary epithelial cells.MEN1, MEN4, and Carney Complex: Pathology and Molecular Geneticsleptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signalingSystemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory targetCyclin D1 determines estrogen signaling in the mammary gland in vivoAltered Expression of Genes in Signaling Pathways Regulating Proliferation of Hematopoietic Stem and Progenitor Cells in Mice with Subchronic Benzene ExposureIdentification of G1-regulated genes in normally cycling human cellsGene network inference and biochemical assessment delineates GPCR pathways and CREB targets in small intestinal neuroendocrine neoplasiaTight function zonula occludens-3 regulates cyclin D1-dependent cell proliferationA Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in miceExposure to nerve growth factor worsens nephrotoxic effect induced by Cyclosporine A in HK-2 cellsNovel interactions between NFATc1 (Nuclear Factor of Activated T cells c1) and STAT-3 (Signal Transducer and Activator of Transcription-3) mediate G protein-coupled receptor agonist, thrombin-induced biphasic expression of cyclin D1, with first phasCyclic-AMP-dependent protein kinase A regulates apoptosis by stabilizing the BH3-only protein BimChanges in the transcriptome of the human endometrial Ishikawa cancer cell line induced by estrogen, progesterone, tamoxifen, and mifepristone (RU486) as detected by RNA-sequencingMolecular mechanisms promoting the pathogenesis of Schwann cell neoplasmsThe complex of myxomas, spotty skin pigmentation and endocrine overactivity (Carney complex): imaging findings with clinical and pathological correlationProtein kinase A effects of an expressed PRKAR1A mutation associated with aggressive tumors.
P2860
Q21245733-C7824834-3C9F-4ED4-9250-296E272BFA1DQ23921356-6D1AA22C-0475-4004-AE45-C722EB186FC6Q24337518-293309B0-DD1B-4179-8073-94CCFCF46631Q24548016-94A650AF-6658-4D43-B97C-ABF9BDF2EED1Q24610494-089A18FA-9F31-4261-BFA2-86096C1C6490Q24616966-D96F08D6-5914-4444-BF2E-D2EBC9FB9D56Q24632775-3EFF22CB-D1C9-4FC8-B261-CD5A727CE398Q24653347-104075D0-1CB3-4748-8935-5D85E39C3CE0Q24676101-DC47C0B7-9C4D-4C03-A0D4-8E0CA681ADBFQ24676129-7FDCF984-022B-4655-BA2F-B3C451924BCBQ26772317-5E7D8EED-C99D-4455-9DDF-FC0897FB1EF6Q26777882-052C0BED-A03F-4F5B-B0F9-7FE130F5FA80Q26784582-CD1D9C66-9289-4500-93A6-9EF371C22FA4Q26796499-4DF380CC-793B-45C9-B8D5-77A065CB230DQ26824561-75AFEBC3-A6ED-4BFA-9666-0E490813819CQ26849995-BC4D3FF2-BEAE-41E3-972F-EA54EA3C6EEDQ27007057-FD0E3ECA-A0A9-439F-90C4-B164B00C78B3Q27026169-5ECDF6CC-C21E-4ADB-9E86-3478144F708FQ27315878-3BED6282-A34E-4752-88AF-11AA4706C625Q27318467-523EB398-9176-47DB-A669-0B8315C8D533Q27319843-D05828A5-934C-4A2B-8E60-355F6CC9F613Q27487978-713BFDCC-F059-4352-A848-77463EE8FBFFQ27690967-67C334B9-D483-4087-B86C-23CF6E617279Q28088746-FE5AAD12-A095-4E2C-B4B4-EE457797E108Q28115934-60FE1BCD-DB09-49B2-BE79-C6E1EADA24A5Q28252084-A4FD6736-FE6B-4A91-9B7E-379C60783B30Q28266775-156988F2-6887-4B65-9E2F-5F5FDC976B1DQ28294725-43667D57-9A53-42A5-8264-8D2D719E78E5Q28387282-44E4A370-4528-4DFE-A382-6D24989246A8Q28474350-95ACD2F5-3FA7-499B-A24F-2CCE7F2E459FQ28476512-AE11F40E-6569-4D9A-8F76-0C1587D4AF54Q28505301-36AEE45E-DB66-485A-91E2-C7A772397D8AQ28533254-A97ACB79-4201-44E1-A366-CB4C8F495C2DQ28534915-F77C5BB9-D680-48AF-8412-B7863AEB1D67Q28567562-A33933B9-B40C-4735-B086-A9A6D81D8547Q28591851-230E6A74-7AC4-4606-8D51-FAAB8D61D19DQ28677420-BCE77768-4097-4E22-9EA9-B7D5B0E905AFQ30457681-5DDAD0B6-5131-436F-811B-9F7BA8FDA199Q30457896-CB88E641-8257-4084-A4E6-65689A136426Q30502101-1764CA95-11E1-454B-A07C-0D2A94EB2EDF
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Minireview: PRKAR1A: normal and abnormal functions
@ast
Minireview: PRKAR1A: normal and abnormal functions
@en
Minireview: PRKAR1A: normal and abnormal functions
@nl
type
label
Minireview: PRKAR1A: normal and abnormal functions
@ast
Minireview: PRKAR1A: normal and abnormal functions
@en
Minireview: PRKAR1A: normal and abnormal functions
@nl
prefLabel
Minireview: PRKAR1A: normal and abnormal functions
@ast
Minireview: PRKAR1A: normal and abnormal functions
@en
Minireview: PRKAR1A: normal and abnormal functions
@nl
P356
P1433
P1476
Minireview: PRKAR1A: normal and abnormal functions
@en
P2093
Constantine A Stratakis
Ioannis Bossis
P304
P356
10.1210/EN.2004-0900
P407
P577
2004-12-01T00:00:00Z